Bora Pharmaceuticals Co Ltd (6472)

Currency in TWD
717.00
+6.00(+0.84%)
Closed·
6472 Scorecard
Full Analysis
Has raised its dividend for 5 consecutive years
6472 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
712.00721.00
52 wk Range
562.00922.00
Key Statistics
Bid/Ask
144.50 / 145.00
Prev. Close
784
Open
712
Day's Range
712-721
52 wk Range
562-922
Volume
773.24K
Average Volume (3m)
1.23M
1-Year Change
-8.43%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6472 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
813.95
Upside
+13.52%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Bora Pharmaceuticals Co Ltd Company Profile

Bora Pharmaceuticals Co., LTD. researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide. The company operates through Sales, Contract Development & Manufacturing Organization, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services, including clinical and commercial manufacturing, pharmaceutical development, packaging and serialization, analytical and microbiology testing, and regulatory affairs services. In addition, it provides food and vitamin supplements, and skincare products; and biotechnical services. The company sells its products directly to clinics, pharmacies, pharmacy chains, and drug stores, as well as through distributors to medical centers, corporate and public hospitals, and regional and district hospitals. Bora Pharmaceuticals Co., LTD. was incorporated in 2007 and is based in Taipei City, Taiwan.

0
Market
Taiwan

Compare 6472 to Peers and Sector

Metrics to compare
6472
Peers
Sector
Relationship
P/E Ratio
14.9x0.0x−0.5x
PEG Ratio
0.250.000.00
Price/Book
6.8x0.0x2.6x
Price / LTM Sales
4.3x0.0x3.3x
Upside (Analyst Target)
14.3%0.0%43.4%
Fair Value Upside
Unlock0.0%7.1%Unlock

Analyst Ratings

7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 813.95
(+13.52% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 33.68%
Dividend Yield
1.63%
Industry Median 2.51%
Annualised payout
11.67
Paid annually
5-Years Growth
+74.57%
Growth Streak

Earnings

Latest Release
Aug 08, 2025
EPS / Forecast
6.34 / 10.27
Revenue / Forecast
5.18B / 5.69B
EPS Revisions
Last 90 days

6472 Income Statement

FAQ

What Stock Exchange Does Bora Pharmas Trade On?

Bora Pharmas is listed and trades on the Taiwan Stock Exchange stock exchange.

What Is the Stock Symbol for Bora Pharmas?

The stock symbol for Bora Pharmas is "6472."

What Is the Bora Pharmas Market Cap?

As of today, Bora Pharmas market cap is 88.98B.

What Is Bora Pharmas's Earnings Per Share (TTM)?

The Bora Pharmas EPS (TTM) is 33.68.

When Is the Next Bora Pharmas Earnings Date?

Bora Pharmas will release its next earnings report on 17 Nov 2025.

From a Technical Analysis Perspective, Is 6472 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Bora Pharmas Stock Split?

Bora Pharmas has split 9 times.

How Many Employees Does Bora Pharmas Have?

Bora Pharmas has 0 employees.

What is the current trading status of Bora Pharmas (6472)?

As of 10 Aug 2025, Bora Pharmas (6472) is trading at a price of 717.00, with a previous close of 784.00. The stock has fluctuated within a day range of 712.00 to 721.00, while its 52-week range spans from 562.00 to 922.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.